Cystic Fibrosis Foundation

Insider Reports History

Location
Bethesda, MD
Signature
/s/ Ania Howell
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Cystic Fibrosis Foundation:

Company Role Class Num Shares Value Price $ Report Date Ownership
BiomX Inc. 10%+ Owner Common Stock, par value $0.0001 per share 1,787,758 $1,663,688 $0.9306 15 Jul 2024 Direct
BiomX Inc. 10%+ Owner Common Stock, par value $0.0001 per share 9,330,580 15 May 2024 Direct
Aridis Pharmaceuticals, Inc. 10%+ Owner Common Stock, par value $0.0001 per share 5,168,732 08 Dec 2022 Direct
BiomX Inc. 10%+ Owner Series X Preferred Stock 13,088 15 Jul 2024 Direct
BiomX Inc. 10%+ Owner Warrant to purchase common stock 0 15 May 2024 Direct

Insider Reports Filed by Cystic Fibrosis Foundation

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PHGE BiomX Inc. 26 Feb 2025 0 $0 4 10%+ Owner 04 Mar 2025, 16:36
PHGE BiomX Inc. 15 Jul 2024 2 $0 5 10%+ Owner 04 Mar 2025, 16:31
PHGE BiomX Inc. 15 May 2024 2 +$4,778 4 10%+ Owner 17 May 2024, 16:05
PHGE BiomX Inc. 16 Mar 2024 0 $0 3 10%+ Owner 26 Mar 2024, 16:30
/report/000089924322038926-cystic-fibrosis-foundation-2022-12-08 Aridis Pharmaceuticals, Inc. 08 Dec 2022 0 $0 3 10%+ Owner 19 Dec 2022, 05:05